PDF is committed to using your funds efficiently to support our mission. To see how funds are spent, browse our financial information.
Hernando Pharmacist to PAIR Up with FDA to Fight Parkinsonís Disease
- Feb 26 2013
Hernando, FL resident Richard Hoffmann, Pharm. D., is bringing his personal passion for Parkinson's research and his professional expertise to a new role as a consumer representative on a committee of the US Food and Drug Administration. In his role on the Peripheral and Central Nervous System Drugs Advisory Committee, Dr. Hoffmann will evaluate potential new drugs to treat the neurological disorders that affect millions of people, including his wife Margaret.
Dr. Hoffmann was selected based upon his experience as a pharmacist and medical writer and his volunteer work as a trained Research Advocate with the Parkinson's Disease Foundation (PDF). He has been active in the Parkinson's disease cause since Margaret was diagnosed with young onset Parkinson's disease five years ago. Last year, the couple underwent training to join PDF's Parkinson's Advocates in Research (PAIR) program, which aims to speed new treatments by pairing people with Parkinson's and care partners with the research community. They spent the past year educating their community about Parkinson's disease research studies.
As for his new appointment, Dr. Hoffmann says it is an opportunity to ensure that the voices of people with Parkinson's disease and their loved ones are heard by the research community.
"I understand all too well from our family's experience the need for better treatments for neurological diseases. My goal is to be a protector of the consumer and the liaison for people who live with neurological diseases such as Parkinson's disease," says Dr. Hoffmann. "I will represent their viewpoint and their urgency, while ensuring that potential new drugs being reviewed are not only effective, but safe."
PDF Executive Director Robin Elliott added, "We congratulate Dr. Hoffmann for this appointment and know that he will be an asset to the FDA. At PDF, we are keenly aware that time is of the essence for people with Parkinson's disease. And we believe that when PDF Research Advocates pair up with the research community, these partnerships will in fact, advance research and speed new treatments for Parkinson's disease."
Dr. Hoffmann's four-year term with the 11-member committee begins this February.
Those interested in learning more about Dr. Hoffmann's appointment or efforts with PAIR can contact the Parkinson's Disease Foundation by calling (800) 457-6676, emailing firstname.lastname@example.org or visiting www.pdf.org/pair.
About Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US. Although promising research is being conducted, there is currently no cure for Parkinson's disease.
About Parkinson's Advocates in Research (PAIR)
Parkinson's Advocates in Research (PAIR) is a signature program of the Parkinson's Disease Foundation (PDF). Through in-person trainings and an online course, it provides people touched by Parkinson's disease with the knowledge and skills needed to "pair up" with scientists and health professionals in advancing research and speeding new treatments. The cornerstone of the program is a national network of 200 Research Advocates from 42 states who guide research, address gaps and obstacles, and educate their communities about research. Their areas of expertise include review of clinical study protocols, development of clinical trial recruitment plans and education of support groups about local research opportunities. Learn more about the program and getting involved in Parkinson's disease research by completing PDF's free Parkinson's Advocates in Research online course at www.pdf.org/pair.
About the Parkinson's Disease Foundation
The Parkinson's Disease Foundation® (PDF®) is a leading national presence in Parkinson's disease research, education and public advocacy. PDF is working for the nearly one million people in the US who live with Parkinson's disease by funding promising scientific research while supporting people living with Parkinson's through educational programs and services. Since its founding in 1957, PDF has dedicated over $96 million to fund the work of leading scientists throughout the world and over $40 million to support national education and advocacy programs.
Source Date: Feb 26 2013